Division of Cardiology, Department of Internal Medicine, Graduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Clin Res Cardiol. 2010 Jul;99(7):437-43. doi: 10.1007/s00392-010-0139-5. Epub 2010 Mar 14.
The aim of this study was to investigate the long-term outcome of unprotected left main coronary artery disease (LMCA) with different therapeutic modalities in Chinese patients.
Coronary artery bypass graft (CABG) has been considered standard therapy for patients with LMCA disease. Percutaneous coronary intervention (PCI) has recently been alternative choice for unprotected LMCA. Nevertheless, the effects on the long-term outcome of unprotected LMCA by the above-mentioned management in Chinese remains unknown.
Patients with unprotected LMCA were enrolled at National Taiwan University Hospital from January 1996 to June 2006. Survival outcomes were obtained by the Bureau of National Health Insurance and clinical results were obtained by chart record review and telephone interview.
A total of 620 patients with a mean age of 67 +/- 10 years were enrolled and followed up for 1,587 +/- 1,136 days. Of these, 136 were treated with medical therapy, 336 with CABG and 148 with PCI. Clinical outcome of patients receiving medical therapy was the worst. There was no significant difference between the PCI and CABG group in the risk of cardiovascular death. Cox regression analysis showed that cardiovascular mortality was significantly associated with age (P < 0.001), diabetes mellitus (P = 0.004), LVEF (P = 0.001). In high-risk left ventricular dysfunction, the elderly and renal insufficiency patients, the long-term survival was statistically significantly better in the CABG group.
For Chinese patients with unprotected left main coronary artery disease, a significant higher risk of cardiovascular death was noted in the medical therapy group. Overall the long-term cardiovascular survival was similar in LMCA patients treated with either PCI or CABG, but CABG provided better survival outcome in high-risk subgroup patients.
本研究旨在探讨不同治疗方式对中国人群无保护左主干冠状动脉疾病(LMCA)的长期预后影响。
冠状动脉旁路移植术(CABG)一直被认为是 LMCA 疾病患者的标准治疗方法。经皮冠状动脉介入治疗(PCI)最近已成为无保护 LMCA 的另一种选择。然而,上述治疗方法对中国人群无保护 LMCA 的长期预后的影响尚不清楚。
1996 年 1 月至 2006 年 6 月,国家台湾大学医院共收治 620 例无保护 LMCA 患者。通过国民健康保险局获得生存结局,通过病历记录回顾和电话访谈获得临床结果。
共纳入 620 例平均年龄 67±10 岁的患者,随访 1587±1136 天。其中 136 例接受药物治疗,336 例接受 CABG 治疗,148 例接受 PCI 治疗。接受药物治疗的患者临床结局最差。PCI 组和 CABG 组在心血管死亡风险方面无显著差异。Cox 回归分析显示,心血管死亡率与年龄(P<0.001)、糖尿病(P=0.004)、LVEF(P=0.001)显著相关。在左心室功能不全、高龄和肾功能不全高危患者中,CABG 组的长期生存率显著提高。
对于中国人群无保护左主干冠状动脉疾病患者,药物治疗组的心血管死亡风险显著增加。总体而言,LMCA 患者接受 PCI 或 CABG 治疗的长期心血管生存率相似,但 CABG 为高危亚组患者提供了更好的生存结局。